PDB33 COST-EFFECTIVENESS OF THE PDM-PROVALUE STUDY PROGRAM IN INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES MELLITUS FROM THE GERMAN STATUTORY HEALTHCARE PERSPECTIVE
Abstract
Authors
F. Sailer M. Pobiruchin A. Müller J. Weissmann L. Heinemann B. Kulzer W. Schramm